Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 2, 2009 - Issue 6
Submit an article Journal homepage
71
Views
4
CrossRef citations to date
0
Altmetric
Review

Finding the place of histone deacetylase inhibitors in prostate cancer therapy

Deborah L Marrocco-Tallarigo Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, University of Adelaide and Hanson Institute, Adelaide, SA 5000, Australia. [email protected]
,
Margaret M Centenera Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, University of Adelaide and Hanson Institute, Adelaide, SA 5000, Australia. [email protected]
,
Howard I Scher Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. [email protected]
,
Wayne D Tilley Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, University of Adelaide and Hanson Institute, Adelaide, SA 5000, Australia. [email protected]
&
Lisa M Butler Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, University of Adelaide and Hanson Institute, Adelaide, SA 5000, Australia. [email protected]
Pages 619-630 | Published online: 10 Jan 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhenghui Liu, Yingxue Gao & Xiong Li. (2019) Cancer epigenetics and the potential of epigenetic drugs for treating solid tumors. Expert Review of Anticancer Therapy 19:2, pages 139-149.
Read now

Articles from other publishers (3)

Amila Suraweera, Kenneth J. O’Byrne & Derek J. Richard. (2018) Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi. Frontiers in Oncology 8.
Crossref
Alfonso Urbanucci & Ian G. Mills. (2018) Bromodomain-containing proteins in prostate cancer. Molecular and Cellular Endocrinology 462, pages 31-40.
Crossref
Victoria L. Luchenko, Thomas Litman, Arup R. Chakraborty, Aaron Heffner, Christopher Devor, Julia Wilkerson, Wilfred Stein, Robert W. Robey, Lois Bangiolo, David Levens & Susan E. Bates. (2014) Histone deacetylase inhibitor‐mediated cell death is distinct from its global effect on chromatin. Molecular Oncology 8:8, pages 1379-1392.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.